A laboratory technician is seen at the Inselspital Universitaetsspital Bern university hospital during researches for a vaccine against the coronavirus disease (COVID-19) in Bern, Switzerland April 22, 2020. "This not going to be an expensive vaccine," Hill told Reuters in an interview. It's going to be made for global supply and it's going to be made in many different locations. Hill's team began early-stage human trials of the vaccine in April, making it one of only a handful to have reached that milestone. "The ambition is shared to get a low-priced, very, very extensively available vaccine as soon as possible," Hill said.

Source: Dhaka Tribune May 15, 2020 14:37 UTC